Chase, J. Geoffrey
Desaive, Thomas
Bohe, Julien
Cnop, Miriam
De Block, Christophe
Gunst, Jan
Hovorka, Roman
Kalfon, Pierre
Krinsley, James
Renard, Eric
Preiser, Jean-Charles
Article History
Received: 8 March 2018
Accepted: 29 June 2018
First Online: 2 August 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: JGC has consulted for Medtronic and Monarch Medical. CDB is a consultant for Abbott, A. Menarini Diagnostics, Medtronic, and Roche Diagnostics. RH reports having received speaker honoraria from Eli Lilly, Novo Nordisk, and Astra Zeneca, serving on advisory panels for Eli Lilly and Novo Nordisk, receiving license fees from BBraun and Medtronic, and having served as a consultant to BBraun. JK is a consultant for Edwards, Medtronic, Roche Diagnostics, and Optiscan. J-CP is a consultant for Edwards, Medtronic, and Optiscan, and is an Associate Editor forCritical Care. The remaining authors declare that they have no conflicts of interest relevant to this article.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.